Life Science Industry Update: October 2017

Posted okt 31, 2017

At LSC we specialise only in Life Sciences and always keep up to date with leading news, projects and all that’s going on in the industry. As the sector sees continued rapid growth it’s easy to miss some of the major announcements. To make things easier and to ensure you too are well informed we’ve selected and summarized this month’s top Irish Life Science industry news stories below.

Regeneron announces 300 additional Jobs & $100 million investment in Limerick

Good news for Limerick as Regeneron Pharmaceuticals announce 300 additional jobs are to be created at their Raheen facility. $100 million will also be invested to further expand its Limerick Industrial Operations and Product Supply (IOPS) bioprocessing campus. The investment will support the construction of a number of pharmaceutical manufacturing suites to increase drug substance production capacity and enable the company to meet demand for its life-transforming medicines for patients with serious diseases.

Following this news total employment is expected to reach 800 at the site and bring total investment to $750 million by the end of 2018. Based in Dell’s old factory in Raheen Business Park, Regeneron’s 400,000 square foot, state-of-the-art production facility is the largest scale bulk biologics production facility in Ireland and one of the largest biologic production operations in the world.  Read More >>

Janssen Sciences Ireland announces expansion to increase production at Ringaskiddy facility

Janssen Sciences in Cork have announced a €300 million investment at their Ringaskiddy facility. The investment will give the business an extra 19,100 sq. meters manufacturing space. The project which is due to commence in October 2017 will create employment for up to 450 people during construction phase and will provide employment to 200 people once complete. The proposed expansion project is expected to take approximately two years and includes the following elements:

  • Construction of a new manufacturing building.
  • Expansion of the existing warehouse building, laboratory and administration buildings.
  • Modification of expansion of other aspects of the existing site and infrastructure, including utilities, car parking, underground services, internal roads, yards and pipe racks.
  • Expansion of the on-site wastewater treatment plant to accommodate increased volumes. Read More >>

Roche Ireland continuing with plans to close Clarecastle plant after failing to sell facility

Unfortunately negotiations to sell the Roche Clarecastle site have failed to reach agreement. Two years ago the company announced it was closing its only Irish manufacturing facility due to a worldwide restructuring of the group, and overcapacity at some of its manufacturing plants. Following further losses Roche are now moving into wind down phase which will take approx. two years with final shutdown in December 2019 resulting in a loss of some 240 jobs. Read More >>

Takeda Ireland bright future ahead

While the news headlines relating to Takeda appear to be negative the underlying facts suggest otherwise. Profits to March 2017 were €5.2 million, down from €102 million a year earlier (€96.8 million reduction). However the decline was principally made up of two factors.

  • Expenses of €25.2 million related to the drug Vocinti which was cancelled during clinical trials
  • A significant increase in administration expenses linked to intra-company transactions. Such costs jumped from €151 million to €247 million last year (€97 million increase in costs).

A drug cancellation during clinical trials and changes in intra-company accounting actually hide a very positive picture for Takeda in Ireland which include:

  • An increase in sales of products produced in Ireland from €357.5 million to €384.9 million (7.6% increase)
  • The continued advancement of the GCP2 new production facility project for NINLARO in Grangecastle. The new production facility is of strategic importance to Takeda and will be unique in that it will house the Drug Substance, Drug Product, Primary and Secondary Packaging and QC processes all under one roof.
  • An increase in R&D staff spend in the Irish operations to €3.98 million

Sometimes a headline can be misleading!

Biopharma Ambition Conference 2018

Dublin will host the major international convention, BioPharma Ambition in 2018, to inspire and showcase innovation in the Biotech industry. The conference, which will be held on 21-22 February 2018, brings together globally renowned experts to discuss the latest research and developments for the industry, and particularly, Ireland’s world-leading reputation as a hub for Biotech manufacturing, Testing, and Research, Development and Innovation (RDI). Registration is now open here!

ISPE Evening seminars November 2017 – February 2018

ISPE Ireland have announced they are holding a series of upcoming evening seminars in Dublin, Cork, Athlone and Limerick. The events are free so early registration is advised. Register here!

Your Next Career Move?

If you want a career in the Life Sciences click here to search the latest jobs on leading industry projects.